CONVATEC INC.
BRIDGEWATER, NJ

ConvaTec Inc. is a global leader in medical products and technologies, focusing on therapies for chronic condition management. The company excels in four key markets: advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's comprehensive product portfolio includes soft cannula and stainless steel infusion sets, as well as skin care products designed for various patient needs. With almost 30 years of experience in infusion care, these products are developed with significant expertise and collaboration with top pharmaceutical companies to support therapies beyond insulin pump therapy, such as treatments for Parkinson’s disease, primary immune deficiencies, thalassaemia, and pain management. ConvaTec Inc., which is incorporated in Florida under the status 'Florida.Models.Dos.FloridaCompanyStatus', had its last event documented on December 1, 2014, classified as a REINSTATEMENT. Based out of Bridgewater, New Jersey with addresses spanning different states like Delaware (home state), and numerous contact points globally, ConvaTec showcases extensive reach. The company was incorporated on April 16, 2009, under the filed number F09000001571 and will file its next annual report by April 24, 2024, covering the year 2024. The leadership at ConvaTec includes key figures such as Chris Sirimis, noted as a Director; Christina Allegrini serving as Secretary; and Divakar Ramakrishnan also listed as a Director among others who contribute to its strategic direction. For more information on their innovative medical solutions or corporate dealings, stakeholders may refer to the company's official website at convatec.com or contact through various numbers provided for customer support, investor relations, and regulatory communications.